Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097–6110
Journal
Current Oncology
ISSN
1718-7729
Date Issued
2024
Author(s)
Alberto Alvarado-Miranda
Fernando Ulises Lara-Medina
Wendy R. Muñoz-Montaño
Juan W. Zinser-Sierra
Paula Anel Cabrera Galeana
Cynthia Villarreal Garza
Daniel Sanchez Benitez
Jesús Alberto Limón Rodríguez
Claudia Haydee Arce Salinas
Alberto Guijosa
Oscar Arrieta
Type
text::journal::journal article
Abstract
<jats:p>In the original publication [...]</jats:p>